Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Inputs in consideration for Pricing LPBI Groups IP Three Classes of Assets: The Intangible Components

 

Curator: Aviva Lev-Ari, PhD, RN

 

• About LPBI Group: Entrepreneurial Venture

 

Executive Summary

https://pharmaceuticalintelligence.com/2019-vista/executive-summary/

 

Founder’s Vision

https://pharmaceuticalintelligence.com/vision/

 

• Leadership by example

 

Reflections on a Four-phase Career: Aviva Lev-Ari, PhD, RN, March 2018

https://pharmaceuticalintelligence.com/2018/03/06/reflections-on-a-four-phase-career-aviva-lev-ari-phd-rn-march-2018/

 

Pioneering implementations of analytics to business decision making: contributions to domain knowledge conceptualization, research design, methodology development, data modeling and statistical data analysis: Aviva Lev-Ari, UCB, PhD’83; HUJI, MA’76

https://pharmaceuticalintelligence.com/2018/05/28/pioneering-implementations-of-analytics-to-business-decision-making-contributions-to-domain-knowledge-conceptualization-research-design-methodology-development-data-modeling-and-statistical-data-a/

 

Thriving at the Survival Calls during Careers in the Digital Age – An AGE like no Other, also known as, DIGITAL

https://pharmaceuticalintelligence.com/2018/06/11/thriving-at-the-survival-calls-during-careers-in-the-digital-age-an-age-like-no-other-also-known-as-digital/

 

 

• Intangible Assets of Firm’s Reputation in the Digital Age

 

The Digital Age Gave Rise to New Definitions – New Benchmarks were born on the World Wide Web for the Intangible Asset of Firm’s Reputation: Pay a Premium for buying e-Reputation

https://pharmaceuticalintelligence.com/2019/07/31/the-digital-age-gave-rise-to-new-definitions-new-benchmarks-were-born-on-the-world-wide-web-for-the-intangible-asset-of-firms-reputation-pay-a-premium-for-buying-e-reputation/

 

For @AVIVA1950, Founder, LPBI Group @pharma_BI:

• Twitter Analytics [Engagement Rate, Link Clicks, Retweets, Likes, Replies] &
• Tweet Highlights [Tweets, Impressions, Profile Visits, Mentions, New Followers]

https://pharmaceuticalintelligence.com/2019/08/06/twitter-analytics-engagement-rate-link-clicks-retweets-likes-replies-tweet-highlights-tweets-impressions-profile-visits-mentions-new-followers-for-aviva1950-founder-lpbi-group-ph/

 

• Components from IP-V-Cal – Tool for IP Valuation of Intangibles

 

Summary Perspectives

 

Executive evaluation of contribution measures in valuation of LPBI Intangibles:

 

A.         Content Creation derived from Domain Knowledge

• ABILITY TO EXTEND INTO NEW DOMAINS
• EXPOITATION OF CURATION METHODOLGIES/TECHNOLOGIES
• ABILITY TO GENERATE NEW/NOVEL CONTENT

B.        Social Media Engagement:

• DEVELOPMENT OF NEW CONTENT/SYMPOSIUM JOURNALS
• EXPLOITATION OF SOCIAL MEDIA – FACEBOOK, LINKED IN
• ENGAGEMENT ON TWITTER

C.       Publishing Excellence

• ARTICLE GENERATION
• WRITING/EDITING SKILLS
• SCIENTIFIC AND CURATION SKILLS

D.       Human Factor The Team

• COMMITMENT TO TEAM

E.      Economic Value in Royalties from Content

• DEVELOPMENT OF TANGIBLE BUSINESS BENEFIT VIA PAGE DOWNLOADS (+100,000), Books Borrowings and Book Sales

Founder’s evaluation of contribution measures in valuation of LPBI Intangibles:

 

A.   Human Factor The Team

• COMMITMENT TO TEAM

B.   Content Creation derived from Domain Knowledge

• ABILITY TO EXTEND INTO NEW DOMAINS
• EXPOITATION OF CURATION METHODOLGIES/TECHNOLOGIES
• ABILITY TO GENERATE NEW/NOVEL CONTENT

C.   Publishing Excellence

• ARTICLE GENERATION
• WRITING/EDITING SKILLS
• SCIENTIFIC AND CURATION SKILLS

D.   Economic Value in Royalties from Content

• DEVELOPMENT OF TANGIBLE BUSINESS BENEFIT VIA PAGE DOWNLOADS (+100,000), Books Borrowings and Book Sales

E.    Social Media Engagement 

• DEVELOPMENT OF NEW CONTENT/SYMPOSIUM JOURNALS
• EXPLOITATION OF SOCIAL MEDIA – FACEBOOK, LINKED IN
• ENGAGEMENT ON TWITTER

Example for 1/1/2019 to 1/7/2019

For @AVIVA1950, Founder, LPBI Group @pharma_BI:

• Twitter Analytics [Engagement Rate, Link Clicks, Retweets, Likes, Replies] &
• Tweet Highlights [Tweets, Impressions, Profile Visits, Mentions, New Followers]

https://pharmaceuticalintelligence.com/2019/08/06/twitter-analytics-engagement-rate-link-clicks-retweets-likes-replies-tweet-highlights-tweets-impressions-profile-visits-mentions-new-followers-for-aviva1950-founder-lpbi-group-ph/

 

The above Summary of Executives and Founder’s Perspectives are derived from inputs submitted by the entire Team, as following:

 

Dr. Williams’ 7 Parameters
1 – Ongoing (currently 7 years article generation on LPBI)	85	3
2 – Co-editor on LPBI ebooks on Amazon and generation of ebook covers	65	1
3 – Daily Engagement on Twitter @pharma_BI, @StephenJWillia2	70	3
4 – Development of Class Curriculum utilizing LPBI site & curation methodology & model for Medical Educational	85	4
5 – Co-development methodology of Scientific Conference Coverage in social media using LPBI platform	70	5
6 – Ongoing and increasing readership on online Journal	85	3
7 – High visibility and reputation of online access Journal and offerings by LPBI	80	6

 

Dr. D. Nir’s 5 Parameters
1 – Originality of content			90	1
2 – Number of market-niche related tangible advice; i.e. action that readers can/should take	90	1	100	4
3 – Team commitment; the level of legally-binding agreements	75	5	100	5
4 – Show cases (testimonials) of specific business consultancy (doesn’t matter if paid or not)	80	2	80	3
5 – Tangible business-benefit attested by followers of the Open Access Online Scientific Journal and by Page downloads from each ebooks [96,000 across all volumes in 4/2019], eBook borrowing and e-Book sales	50	4	80	2

 

Dr. Irina Robu 5 Parameters
1- Ongoing (currently 7 years article generation on LPBI)	1	1	100	89	2
2 – Brought strong writing/editing skills to LPBI	2	2	95	80	1
3 – Regular engagement on Twitter @pharma_BI, @irirobu	3	3	70	60	4
4 – Editor on 3-D Bioprinting LPBI ebook on Amazon and participating writer on other LPBI ebooks	2	2	90	90	3
5-Team Commitment; Information organizer and IT	5	5	85	60	5

 

Gail’s 5 Parameters
1 – Expertise and dedication of highly experienced group of consultants who offer synthesis, analysis and interpretation of complex medical and scientific areas	90	1	40	1
2 – Expertise and dedication of highly experienced group of consultants who offer synthesis, analysis and interpretation of complex medical and scientific areas	60	4	20	2
3 -Brought strong strategy and writing/editing skills to LPBI	60	2	20	3
4 -Wrote original patient-focused articles for Voices of Patients e-book + continued article publishing	80	3	10	4
5 -Explored new and different communications avenues, i.e, recent Bioprinting audio podcast brings 40,000 new listeners	70	5	10	5

 

Amnon’s Parameters
Who cares (the audience)?	70	4	100	The scientists should answer it
Why do the audience care?	80	3	100
How does the audience use the service/product?	90	1	100
What is the real experience of using the LPBI products and services (testimonials)	80	2	100

 

Aviva’s Parameters
1 – Low barriers to entry		10	95
2 – Zero labor cost		8	100	1
3 – Virtual no overhead		7	100	1
4 – Run rate Hosting website $200/yr			95	5
5 – LinkedIn Corp Account $1000/yr			95	5
6 – Leadership demonstrated CAPACITY for new domain entry			100	3
7 – Team ability to swarm to new domains			100	2
8 – Leadership maintains Fidelity of Scientists Core			100	1
9 – Founder’s ability to multitask 5 people in One person		1	100	1
10A – Daily Engagement in Twitter @pharma_Bi # Followers = 519 RatioTweets to Likes: 25,000/3,086		2	95	5
10B – @AVIVA1950 # Followers = 439 RatioTweets to Likes: 11,000/5,615		2	100	5
11 – Daily engagement in LinkedIn 7,000 1st contacts		3	90	4
12 – Daily engagement in Facebook		4	50	5
13 – In-Person at 60 confrences brinking back contacts and Ideas		1	100	1
14 – 60 conferences yielded Corpus of eProceedings – IP Asset Class III [10 by Dr. Williams N= 70]		2	100	1
15 – Founder as Curator of New content – Journal is LIVE		1	100	3
16 – Founder as Book Editor in multiple domains: Series A, B, D, E		4	98	3
17 – Founder as Editor-in-Chief: 16 Titles, content acquisition, eTOCs Designer		2	150	2
18. – Founder as Relations builder with multiple Ecosystems: Israel, US, Europe, Japan		3	120	1